Selection strategy of second-line biologic therapies in adult patients with ulcerative colitis following prior biologic treatment failure: Systematic review and meta-analysis
Background: Optimizing second-line biologic therapies for adult ulcerative colitis (UC) post first-line failure is essential. Objective: Compare second-line biologic therapy efficacy in adult UC patients with prior treatment failure. Methods: A comprehensive search of electronic databases up to May...
Main Authors: | Hu Zhang, Chenlu Mu, Yu Gu, Fanyi Meng, Xiali Qin, Hailong Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661824000525 |
Similar Items
-
A Novel Nomogram Combining Mucus Barrier Index for Predicting Treatment Failures in Ulcerative Colitis
by: Wang Y, et al.
Published: (2023-05-01) -
Clinical, biochemical, endoscopic and histopathological evaluation of biological treatment in ulcerative colitis
by: Carlos A. López-Bernal, et al.
Published: (2022-10-01) -
Ulcerative colitis – recent and potential methods of treatment - review
by: Mikołaj Tomasik, et al.
Published: (2023-01-01) -
Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
by: Xinqiao Chu, et al.
Published: (2023-10-01) -
Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
by: Kyuwon Kim, et al.
Published: (2022-11-01)